Relationship of circulating tumor DNA (ctDNA) tumor fraction with prognosis in patients with metastatic pancreatobiliary cancer

被引：0
|
作者：
Pathak, Priyadarshini
Li, Gerald
Quintanilha, Julia
Keller-Evans, Rachel B.
Pasquina, Lincoln W.
Thierauf, Julia
Elvin, Julia A.
Ross, Jeffrey S.
Graf, Ryon P.
Parikh, Aparna Raj
Pishvaian, Michael J.
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Fdn Med Inc, Boston, MA USA
[3] Fdn Med Inc, Cambridge, MA USA
[4] Fdn Med Inc, San Diego, CA USA
[5] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA USA
[6] Johns Hopkins Univ, Dept Pediat, Sch Med Washington, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.763
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
763
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Impact in prognosis of circulating tumor DNA mutant allele fraction (MAF) in RAS mutant metastatic colorectal cancer (mCRC)
    Sanz-Garcia, Enrique
    Elena, Elez
    Ginevra, Caratu
    Judit, Matito
    Ariadna, Garcia
    Julieta, Grasselli
    Mercedes, Martinez-Villacampa
    Cristina, Santos
    Nuria, Mulet
    Joana, Vidal
    Guillem, Argiles
    Teresa, Macarulla
    Jaume, Capdevila
    Tamara, Sauri
    Ignacio, Matos
    Enrique, Aranda
    Frederick, Jones
    Rodrigo, Dientsmann
    Clara, Montagut
    Josep, Tabernero
    Ramon, Salazar
    Ana, Vivancos
    ANNALS OF ONCOLOGY, 2017, 28
  • [42] Circulating tumor DNA (ctDNA) trajectories predict survival in trifluridine/tipiracil-treated metastatic colorectal cancer patients
    Unseld, Matthias
    Kuehberger, Stefan
    Graf, Ricarda
    Beichler, Christine
    Braun, Markus
    Dandachi, Nadia
    Heitzer, Ellen
    Prager, Gerald W.
    MOLECULAR ONCOLOGY, 2025,
  • [43] Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer
    Bando, Hideaki
    Nakamura, Yoshiaki
    Taniguchi, Hiroya
    Shiozawa, Manabu
    Yasui, Hisateru
    Esaki, Taito
    Kagawa, Yoshinori
    Denda, Tadamichi
    Satoh, Taroh
    Yamazaki, Kentaro
    Sunakawa, Yu
    Kato, Takeshi
    Goto, Masahiro
    Yuki, Satoshi
    Nishina, Tomohiro
    Oki, Eiji
    Shinozaki, Eiji
    Matsuhashi, Nobuhisa
    Takahashi, Naoki
    Tsuji, Akihito
    Ohtsubo, Koushiro
    Wakabayashi, Masashi
    Ikeno, Takashi
    Hata, Masayuki
    Odegaard, Justin, I
    Yoshino, Takayuki
    JCO PRECISION ONCOLOGY, 2022, 6
  • [44] Detection of Mutant Circulating Tumor DNA (ctDNA) in Plasma of Patients With Colorectal Cancer (CRC)
    Dworniczak, Juliane
    Rossenbach, Christiana
    Reisch, Simone
    Hart, Christian
    Fuzesi, Laszlo
    Dockhorn-Dworniczak, Barbara
    Dworniczak, Bernd
    LABORATORY INVESTIGATION, 2015, 95 : 513A - 513A
  • [45] Detection of Mutant Circulating Tumor DNA (ctDNA) in Plasma of Patients With Colorectal Cancer (CRC)
    Dworniczak, Juliane
    Rossenbach, Christiana
    Reisch, Simone
    Hart, Christian
    Fuzesi, Laszlo
    Dockhorn-Dworniczak, Barbara
    Dworniczak, Bernd
    MODERN PATHOLOGY, 2015, 28 : 513A - 513A
  • [46] Predictive and prognostic value of circulating tumor DNA (ctDNA) compared to circulating tumor cells (CTC) in a prospective cohort of metastatic breast cancer patients: The UCBG COMET trial
    Pierga, Jean-Yves
    Silveira, Amanda
    Girard, Elodie
    Lorgis, Veronique
    Tanguy, Marie-Laure
    Albaud, Benoit
    Tredan, Olivier
    Dubot, Coraline
    Hego, Caroline
    Jacot, William
    Goncalves, Anthony
    Debled, Marc
    Levy, Christelle
    Ferrero, Jean-Marc
    Jouannaud, Christelle
    Mouret-Reynier, Marie-Ange
    Dalenc, Florence
    Baulande, Sylvain
    Lemonnier, Jerome
    Berger, Frederique
    Bidard, Francois-Clement
    Proudhon, Charlotte
    CANCER RESEARCH, 2020, 80 (16)
  • [47] Circulating Tumor DNA (ctDNA) as a Marker of Progressive Disease in Patients with Advanced Lung Cancer
    Ulrich, B.
    Paweletz, C.
    Milan, M.
    Oxnard, G.
    Janne, P.
    Rotow, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S416 - S416
  • [48] Association of circulating tumor DNA (ctDNA) detection in metastatic renal cell carcinoma (mRCC) with tumor burden
    Maia, Manuel Caitano
    Bergerot, Paulo Gustavo
    Dizman, Nazli
    Hsu, Joann
    Jones, Jeremy
    Choueiri, Toni K.
    Sonpavde, Guru
    Lannnan, Richard B.
    Banks, Kimberly
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] ESR1 mutations in circulating tumor DNA (ctDNA) are associated with CTCs and increased hormone receptors in metastatic tumor tissues of patients with metastatic breast cancer (MBC).
    Zhang, Qiang
    Qin, Weijun
    D'Amico, Paolo
    Jiao, Jianhua
    Davis, Andrew A.
    Gerratana, Lorenzo
    Donahue, Jeannine
    Reduzzi, Carolina
    Manai, Marwa
    Jacob, Saya
    Zhang, Youbin
    Flaum, Lisa E.
    Behdad, Amir
    Cristofanilli, Massimo
    Platanias, Leonidas C.
    Shah, Ami N.
    Gradishar, William John
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] ANALYSIS OF THE PROGNOSTIC SIGNIFICANCE OF CIRCULATING TUMOR DNA (CTDNA) IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER (MCRPC)
    Shaya, Justin
    Randall, J. Michael
    Millard, Frederick
    Kurzrock, Razelle
    Parsons, J. Kellogg
    Tamayo, Pablo
    McKay, Rana
    JOURNAL OF UROLOGY, 2020, 203 : E1094 - E1095
12345